Donepezil (Donasure (5 mg)) is a cholinesterase inhibitor, prescribed for dementia of Alzheimer's disease. It works by increasing the amount of acetylcholine in the brain, which helps in improving ...

July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...

HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy's Laboratories (NYS: RDY) announced yesterday that it has launched Donepezil Hydrochloride Tablets, 23 mg, a therapeutic equivalent generic version of ...

Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...

Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's disease. It is not known whether treatment benefits continue after the ...

Dr. Reddy’s Laboratories has launched Donepezil Hydrochloride Tablets, 23 mg, a therapeutic equivalent generic version of ARICEPT®, 23 mg in the US market on July 26, 2013, following the approval by ...

Abbreviations: COWA, Controlled Oral Word Association Test; DST, Digit Span Test; GP, Grooved Pegboard; HVLT-R, Hopkins Verbal Learning Test–Revised; LS, least ...

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Aricept ® Patch ...

Ranbaxy Laboratories Ltd has submitted to BSE a copy of Press Release dated January 08, 2014 titled "Ranbaxy receives approval to market RANTM Donepezil in Canada" Ranbaxy Pharmaceuticals Canada Inc. ...

Ranbaxy Pharmaceuticals Canada Inc (RPCI), a wholly-owned subsidiary of Ranbaxy, announced that it has received approval in December to manufacture and market RAN-Donepezil Hydrochloride 5 mg and 10 ...